Published in Neurology on June 10, 2008
Cutaneous allodynia in the migraine population. Ann Neurol (2008) 2.75
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09
Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective. Headache (2011) 1.40
Central sensitization theory of migraine: clinical implications. Headache (2006) 1.40
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache (2004) 1.39
Is botulinum toxin useful in treating headache? Yes. Curr Treat Options Neurol (2009) 1.38
Can allodynic migraine patients be identified interictally using a questionnaire? Neurology (2005) 1.31
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache (2006) 1.27
Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache (2013) 1.17
DHE in the pharmacotherapy of migraine: potential for a larger role. Headache (2006) 1.17
Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol (2008) 1.14
Measuring migraine-related quality of care across 10 health plans. Am J Manag Care (2012) 1.08
Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache (2004) 0.96
Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients. Headache (2006) 0.93
Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache (2009) 0.92
The evolution of chronic migraine: classification and nomenclature. Headache (2009) 0.91
Migraine prophylaxis with botulinum toxin A is associated with perception of headache. Toxicon (2009) 0.88
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs (2006) 0.88
Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs (2008) 0.88
The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache (2007) 0.87
Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs. Headache (2007) 0.86
Patients' preference for migraine preventive therapy. Headache (2007) 0.85
Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica? Neurol Res (2006) 0.84
Quality of care measures for migraine: a comprehensive review. Dis Manag (2007) 0.84
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache (2012) 0.83
Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache (2009) 0.82
Inpatient treatment of headache: an evidence-based assessment. Headache (2004) 0.82
Menstrual migraine: a review of hormonal causes, prophylaxis and treatment. Expert Opin Pharmacother (2007) 0.81
Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope. Arq Neuropsiquiatr (2008) 0.81
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. Cephalalgia (2010) 0.80
Use of common migraine treatments in breast-feeding women: a summary of recommendations. Headache (2013) 0.80
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study. Headache (2011) 0.78
Paraneoplastic neuropathies. Continuum (Minneap Minn) (2014) 0.78
Frovatriptan as preemptive treatment for fasting-induced migraine. Headache (2011) 0.77
Assessing quality of care for migraineurs: a model health plan measurement set. Popul Health Manag (2008) 0.77
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study. Postgrad Med (2013) 0.77
Is there a preferred triptan? Headache (2002) 0.76
Progressive weakness with respiratory failure in a patient with sarcoidosis. Arch Neurol (2012) 0.75
Expanding access to triptans: assessment of clinical outcome. Headache (2009) 0.75
Beyond intravenous thrombolysis. CNS Spectr (2007) 0.75
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials. Headache (2013) 0.75
Considerations in the treatment of tension-type headache in the elderly. Drugs Aging (2014) 0.75
Disproportionate pupillary involvement in diabetic autonomic neuropathy. Clin Auton Res (2014) 0.75
Slowly progressive ataxia, neuropathy, and oculomotor dysfunction. Arch Neurol (2012) 0.75